[1] 艾丽丽，郁莉斐，顾莺，等.难治性癫痫患儿生酮饮食治疗的依从性现状及相关性研究[J].癫痫杂志,2023,9(1):16-21.
[2] 万鑫，王新强，袁凯杰.甲泼尼龙联合丙戊酸钠治疗难治性癫痫患儿疗效的影响因素[J].神经损伤与功能重建,2023,18(2):115-116,124.
[3] SETO E S,COORG R.Epilepsy Surgery[J].Neurologic Clinics,2021,39(3):723-742.
[4] RAVINDRA V M,SWENEY M T,BOLLO R J.Recent developments in the surgical management of paediatric epilepsy[J].Arch Dis Child,2017,102(8):760-766.
[5] BERNASCONI A,CENDES F,THEODORE W H,et al.Recommendations for the use of structural magnetic resonance imaging in the care of patients with epilepsy:a consensus report from the international league against epilepsy neuroimaging task force[J].Epilepsia,2019,60(6):1054-1068.
[6] 闫昕，曹守明.难治性颞叶癫痫患者行前颞叶切除术后认知功能和生活质量的临床疗效探究[J].现代医学,2018,46(2):153-156.
[7] KOUTSOURAS G W,HALL W A.Surgery for pediatric drug resistant epilepsy:a narrative review of its history,surgical implications,and treatment strategies[J].Transl Pediatr,2023,12(2):245-259.
[8] CURRY D J,GOWDA A,MCNICHOLS R J,et al.MR-guided stereotactic laser ablation of epileptogenic foci in children[J].Epilepsy Behav,2012,24(4):408-414.
[9] ISNARD J,TAUSSIG D,BARTOLOMEI F,et al.French guidelines on stereoelectroencephalography (SEEG)[J].Neurophysiol Clin,2018,48(1):5-13.
[10] MCGONIGAL A,SAHGAL A,DE SALLES A,et al.Radiosurgery for epilepsy:systematic review and International Stereotactic Radiosurgery Society (ISRS) practice guideline[J].Epilepsy Res,2017,137:123-131.
[11] GUAN J,KARSY M,DUCIS K,et al.Surgical strategies for pediatric epilepsy[J].Transl Pediatr,2016,5(2):55-66.
[12] BATSON S,SHANKAR R,CONRY J,et al.Efficacy and safety of VNS therapy or continued medication management for treatment of adults with drug-resistant epilepsy:systematic review and Meta-analysis[J].J Neurol,2022,269(6):2874-2891.
[13] NAGAHAMA Y,ZERVOS T M,MURATA K K,et al.Real-world preliminary experience with responsive neurostimulation in pediatric epilepsy:a multicenter retrospective observational study[J].Neurosurg,2021,89(6):997-1004.
[14] JIMMY C Y,KATIE L B,FAICAL I,et al.Centromedian thalamic deep brain stimulation for drug-resistant epilepsy:single-center experience[J].J neurosurg,2022,137(6):1591-1600.
[15] NOWAKOWSKA M,VÇAL M,CHARALAMBOUS M,et al.Neurostimulation as a method of treatment and a preventive measure in canine drug-resistant epilepsy:current state and future prospects[J].Front Vet Sci,2022,9:889561.
[16] SAMPAIO L P.Ketogenic diet for epilepsy treatment[J].Arq Neuro psiquiatr.,2016,74(10):842-848.
[17] LIM J M,LETCHUMANAN V,TAN L T H,et al.Ketogenic diet:a dietary intervention via gut microbiome modulation for the treatment of neurological and nutritional disorders (a narrative review)[J].Nutrients,2022,14(17):3566.
[18] ZHANG Y,ZHOU S,ZHOU Y,et al.Altered gut microbiome composition in children with refractory epilepsy after ketogenic diet[J].Epilepsy Res,2018,145:163-168.
[19] NEAL E G,CHAFFE H,SCHWARTZ R H,et al.The ketogenic diet for the treatment of childhood epilepsy:a randomised controlled trial[J].Lancet Neurol,2008,7(6):500-506.
[20] KOSSOFF E H,ZUPEC-KANIA B A,AMARK P E,et al.Optimal clinical management of children receiving the ketogenic diet:recommendations of the international ketogenic diet study group:consensus statement for the ketogenic diet[J].Epilepsia,2009,50(2):304-317.
[21] IMDAD K,ABUALAIT T,KANWAL A,et al.The metabolic role of ketogenic diets in treating epilepsy[J].Nutrients,2022,14(23):5074.
[22] LUCCHI C,MARCHIÒ M,CARAMASCHI E,et al.Electrographic changes accompanying recurrent seizures under ketogenic diet treatment[J].Pharmaceuticals,2017,10(4):82.
[23] MAZURKIEWICZ-BEȽDZISKA M,ZAWADZKA M.Use of cannabidiol in the treatment of epilepsy[J].Neurol Neurochir Pol,2022,56(1):14-20.
[24] OAROWSKI M,KARPISKI T M,ZIELISKA A,et al.Cannabidiol in neurological and neoplastic diseases:latest developments on the molecular mechanism of action[J].IJMS,2021,22(9):4294.
[25] GRAY R A,WHALLEY B J.The proposed mechanisms of action of CBD in epilepsy[J].Epileptic Disord,2020,22(S1):10-15.
[26] NABBOUT R,MISTRY A,ZUBERI S,et al.Fenfluramine for treatment-resistant seizures in patients with dravet syndrome receiving stiripentol-inclusive regimens:a randomized clinical trial[J].JAMA Neurol,2020,77(3):300-308.
[27] SIMON K,SHECKLEY H,ANDERSON C L,et al.A review of fenfluramine for the treatment of Dravet syndrome patients[J].Curr Res Pharmacol Drug Discov,2021,3:100078.
[28] VERROTTI A,GRASSO E A,CACCIATORE M,et al.Potential role of brivaracetam in pediatric epilepsy[J].Acta Neurol Scand,2021,143(1):19-26.
[29] 孙玉瑶，杨欣伟.吡仑帕奈治疗儿童癫痫的研究进展[J].癫痫杂志,2023,9(3):218-223.
[30] SINGH A.Cenobamate for treatment-resistant focal seizures:current evidence and place in therapy[J].J Cent Nerv Syst Dis,2022,14:117957352110702.
[31] RADEMACHER M,TOLEDO M,VAN PAESSCHEN W,et al.Efficacy and safety of adjunctive padsevonil in adults with drug-resistant focal epilepsy:results from two double-blind,randomized,placebo-controlled trials[J].Epilepsia Open,2022,7(4):758-770.
[32] DE GIOIA R,BIELLA F,CITTERIO G,et al.Neural stem cell transplantation for neurodegenerative diseases[J].IJMS,2020,21(9):3103.
[33] ALAYLI A,LOCKARD G,GORDON J,et al.Stem cells:recent developments redefining epilepsy therapy[J].Cell Transplant,2023,32:096368972311589.
[34] SADANANDAN N,SAFT M,GONZALES-PORTILLO B,et al.multipronged attack of stem cell therapy in treating the neurological and neuropsychiatric symptoms of epilepsy[J].Front Pharmacol,2021,12:596287.
[35] HAMMAD M,SCHMIDT S L,ZHANG X,et al.Transplantation of GABAergic interneurons into the neonatal primary visual cortex reduces absence seizures in stargazer mice[J].Cereb Cortex,2015,25(9):2970-2979.
[36] LUO Q,XIAN P,WANG T,et al.Antioxidant activity of mesenchymal stem cell-derived extracellular vesicles restores hippocampal neurons following seizure damage[J].Theranostics,2021,11(12):5986-6005.
[37] CHANG B L,CHANG K H.Stem cell therapy in treating epilepsy[J].Front Neurosci,2022,16:934507.
[38] SHAIMARDANOVA A A,CHULPANOVA D S,MULLAGULOVA A I,et al.Gene and cell therapy for epilepsy:a mini review[J].Front Mol Neurosci,2022,15:868531.
[39] SNOWBALL A,CHABROL E,WYKES R C,et al.Epilepsy gene therapy using an engineered potassium channel[J].J Neurosci,2019,39(16):3159-3169.
[40] SHIMAZAKI K,KOBARI T,OGURO K,et al.Hippocampal GAD67 transduction using rAAV8 regulates epileptogenesis in EL mice[J].Mol Ther Methods Clin Dev,2019,13:180-186.
[41] YOUNG D,FONG D M,LAWLOR P A,et al.Adenosine kinase,glutamine synthetase and EAAT2 as gene therapy targets for temporal lobe epilepsy[J].Gene Ther,2014,21(12):1029-1040.
[42] RONZITTI G,GROSS D A,MINGOZZI F.Human immune responses to adeno-associated virus (AAV) vectors[J].Front Immunol,2020,11:670.
[43] COLASANTE G,QIU Y,MASSIMINO L,et al.In vivo CRISPRa decreases seizures and rescues cognitive deficits in a rodent model of epilepsy[J].Brain,2020,143(3):891-905
[44] BONILLA L,ESTERUELAS G,ETTCHETO M,et al.Biodegradable nanoparticles for the treatment of epilepsy:from current advances to future challenges[J].Epilepsia Open,2022,7(S1):S121-S132.
[45] ADHIKARI C.Polymer nanoparticles-preparations,applications and future insights:a concise review[J].POLYM-PLAST TECH MAT,2021,60(18):1996-2024.
[46] MOVAHEDPOUR A,TAGHVAEEFAR R,ASADI-POOYA A,et al.Nano-delivery systems as a promising therapeutic potential for epilepsy:current status and future perspectives[J].CNS Neurosci Ther,2023:29(11):3150-3159.
[47] 卢倩，张淇，王秋红，等.外泌体在癫痫的诊断与治疗中的应用[J].癫痫杂志,2023,9(4):306-309. |
